Yair Seroussi - 18 Mar 2026 Form 3 Insider Report for Enlight Renewable Energy Ltd. (ENLT)

Role: Director, VICE CHAIRMAN OF THE BOARD
Signature: /s/ Helit Megido as attorney-in-fact for Yair Seroussi
Issuer symbol: ENLT
Transactions as of: 18 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Mar 2026, 17:00:36 UTC
Previous filing: 16 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
SEROUSSI YAIR	Director, VICE CHAIRMAN OF THE BOARD	C/O ENLIGHT RENEWABLE ENERGY LTD., 13 AMAL ST. AFEK INDUSTRIAL PARK, ROSH HA'AYIN, ISRAEL	/s/ Helit Megido as attorney-in-fact for Yair Seroussi	18 Mar 2026	0001217656

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ENLT	Ordinary shares, NIS 0.1 par value per share						14,233	18 Mar 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ENLT	Stock Options (right to buy)							18 Mar 2026	Ordinary shares, NIS 0.1 par value per share	71,000	$23.22	Direct	F2, F3
holding	ENLT	Stock Options (right to buy)							18 Mar 2026	Ordinary shares, NIS 0.1 par value per share	51,574	$27.33	Direct	F4, F5
holding	ENLT	Performance-Based RSUs							18 Mar 2026	Ordinary shares, NIS 0.1 par value per share	11,339		Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	(Includes 10,675 restricted share units granted on April 17, 2024, with 3,558 vesting on each of April 17, 2026 and April 17, 2027, and 3,559 vesting on April 17, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
F2	Stock options were granted on September 30, 2021, with 8,875 having vested on each of December 30, 2023, March 30, 2024, June 30, 2024, September 30, 2024, December 30, 2024, March 30, 2025, June 30, 2025, and September 30, 2025.
F3	Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
F4	Stock options were granted on October 1, 2025, with 12,893 vesting on each of October 1, 2026, and October 1, 2028, and 12,894 vesting on each of October 1, 2027, and October 1, 2029.
F5	Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
F6	Performance-based RSUs ("PSUs") were granted on October 1, 2025 and vest in four annual tranches: 2,834 on October 1, 2026, and 2,835 on each of October 1, 2027, 2028, and 2029, subject to continued service as an office holder and achievement of performance metrics for the preceding calendar year. The metrics, Total Income and Revenues, and Adjusted EBITDA (each as reported in the Company's Annual Report on Form 20-F), are measured against the midpoint of the Company's forecast published at the start of the applicable performance year. Achievement of 90% of the target yields 50% vesting for that metric's portion of the tranche, with linear interpolation for achievement between 90% and 100%. Metrics are weighted equally and evaluated independently; overperformance in one cannot offset the other. Each PSU represents a contingent right to receive one ordinary share of the Company upon vesting.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney by Yair Seroussi